biotechnology
-

New Horizons in Pancreatic Oncology: Can-Fite Moves to Phase 2b as Mitochondrial ‘Addiction’ Discovery Unveils Fatal Vulnerability
Significant clinical and biological breakthroughs are reshaping the landscape of pancreatic adenocarcinoma treatment, led by Can-Fite’s advancement of Namodenoson to Phase 2b and the discovery of a mitochondrial inflammatory pathway that fuels tumor growth.
-

Mpox Vaccine Market Shifts Amid Global Outbreak Surge
As Mpox outbreaks intensify in Pakistan and Ghana, biotechnology firms are racing to break the single-supplier vaccine monopoly to meet surging global demand.
-

Optimizing Surface Cultivation: How Process Parameters Shape Single-Cell Oil Production in Cutaneotrichosporon oleaginosus
This article explores how response surface methodology is revolutionizing the production of single-cell oils from Cutaneotrichosporon oleaginosus, highlighting the influence of temperature, pH, and dissolved oxygen on lipid yield and fatty acid composition—key factors for sustainable and scalable microbial oil…
-

U.S. Halts mRNA Vaccine Research Funding: Implications for Global Health
The U.S. government has canceled $500 million in funding for mRNA vaccine development, sparking concerns about the future of pandemic preparedness and advancements in biotechnology.
-

Sarepta Therapeutics Restructures Amid Challenges with Gene Therapy Elevidys
Sarepta Therapeutics has announced a major restructuring, laying off 36% of its workforce and shifting its research focus amid safety concerns surrounding its gene therapy Elevidys.
-

How AI Is Revolutionizing Protein Science with AlphaFold3
Google DeepMind’s AlphaFold3 is transforming protein science by predicting molecular shapes, paving the way for breakthroughs in medicine and climate solutions.
-

26 New Microbe Species Found in NASA Cleanrooms: Study
Scientists discover 26 novel microbe species thriving in NASA cleanrooms, sparking concerns over space contamination and biotechnological opportunities.
-

SOHM Launches AI Team to Boost Genome Editing Technology
SOHM, Inc., a pharmaceutical and biotechnology company, announced the formation of a dedicated AI team on April 7, 2025, to enhance its ABBIE genome editing system and develop innovative RNA-guided tools for advancements in gene therapy and other fields.
-

Apellis Pharmaceuticals Strengthens Position in Rare Disease Treatment with $709 Million Revenue in 2024
Apellis Pharmaceuticals, a global biopharmaceutical leader, has closed 2024 with robust financial results, reporting $709 million in U.S. net product revenues. This impressive performance reflects the success of SYFOVRE®, its groundbreaking treatment for geographic atrophy (GA), which generated $611 million…
-

Bioptimus Secures $76 Million to Unify Biology with AI, Launching Groundbreaking Foundation Model in 2025
Bioptimus, an innovative AI-driven biology company, has secured $76 million in funding, including a $41 million Series A round led by Cathay Innovation. This milestone supports the development of a groundbreaking multi-scale, multi-modal foundation model for biology, slated for release…

